Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis

¹ Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
² Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

^* To whom correspondence should be addressed.

	Abstract

Cognitive dysfunction is common in patients with multiple sclerosis (MS), and has been associated with MRI measures of lesion burden and atrophy. Little is known about the prevalence of cognitive impairment in patients with early MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course are also unclear. This study used a brief battery of cognitive tests to determine the prevalence and pattern of cognitive impairment in patients with clinically isolated syndromes or newly diagnosed MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course were also examined. Ninety-two patients with clinically isolated syndromes or the diagnosis of MS within the last 3 years participating in the CLIMB study underwent a neurologic examination, neuropsychological evaluation and MRI at 1.5T. Forty-nine percent of patients were impaired on one or more cognitive measures. There were no significant correlations between cognitive scores and MRI measures of disease severity including total T2 lesion volume, normal appearing white matter volume, grey matter volume, and brain parenchymal fraction. These findings suggest that cognitive impairment may predate the appearance of gross structural abnormalities on MRI and serve as an early marker of disease activity in MS.

Key Words: clinically isolated syndrome; cognition disorder; magnetic resonance imaging; multiple sclerosis

First published on July 10, 2007, doi:10.1177/1352458507077943

Multiple Sclerosis 2007;13:1004.

A more recent version of this article appeared on September 1, 2007


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Morrow, B Weinstock-Guttman, F. Munschauer, D Hojnacki, and R. Benedict Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis Multiple Sclerosis, August 1, 2009; 15(8): 998 - 1005. [Abstract] [PDF]

				F Patti, M. Amato, M Trojano, S Bastianello, M. Tola, B Goretti, L Caniatti, E Di Monte, P Ferrazza, V Brescia Morra, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study Multiple Sclerosis, July 1, 2009; 15(7): 779 - 788. [Abstract] [PDF]

				F. Patti, M. Pia Amato, S. Bastianello, L. Caniatti, E. Di Monte, F. Lijoi, B. Goretti, S. Messina, O. Picconi, M. R. Tola, et al. Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing--remitting multiple sclerosis: 2-year results from the COGIMUS study Therapeutic Advances in Neurological Disorders, March 1, 2009; 2(2): 67 - 77. [Abstract] [PDF]

				R G Henry, M Shieh, D T Okuda, A Evangelista, M L Gorno-Tempini, and D Pelletier Regional grey matter atrophy in clinically isolated syndromes at presentation J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1236 - 1244. [Abstract] [Full Text] [PDF]

				P Nilsson, I Rorsman, E. Larsson, B Norrving, and M Sandberg-Wollheim Cognitive dysfunction 24-31 years after isolated optic neuritis Multiple Sclerosis, August 1, 2008; 14(7): 913 - 918. [Abstract] [PDF]

				B Duque, J Sepulcre, B Bejarano, L Samaranch, P Pastor, and P Villoslada Memory decline evolves independently of disease activity in MS Multiple Sclerosis, August 1, 2008; 14(7): 947 - 953. [Abstract] [PDF]